Literature DB >> 28738540

Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance.

Kunnathur Murugesan Sakthivel1, Sreedharan Hariharan2.   

Abstract

DNA damaging agents are most common in chemotherapeutic molecules that act against cancer. However, cancer cells possess inherent biological features to overcome DNA damages by activating various distinct repair mechanisms and pathways. Importantly, various oncogenes, cancer stem cells (CSCs), hypoxic environment, transcription factors and bystander signaling that are activated in the cancer cells influence DNA repair, thereby effectively repairing the DNA damage. Repaired cancer cells often become more resistance to further therapy and results in disease recurrence. In this review, we summarize how the various signaling pathways in cancer cells regulates DNA repair and induce chemoresistance.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bystander signaling and cancer stem cells; Chemoresistance; DNA repair; Hypoxia; Oncogenes

Mesh:

Year:  2017        PMID: 28738540     DOI: 10.1016/j.biopha.2017.07.035

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

Review 1.  Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome.

Authors:  Mahesh Manjunath Gouda; Sadiya B Shaikh; Yashodhar Prabhakar Bhandary
Journal:  Lung       Date:  2018-08-18       Impact factor: 2.584

Review 2.  Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Authors:  Moein Ala; Mahan Ala
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-01

3.  The role of toll-like receptors (TLRs) in pan-cancer.

Authors:  Runzhi Huang; Zehui Sun; Shuyuan Xian; Dianwen Song; Zhengyan Chang; Penghui Yan; Jie Zhang; Huabin Yin; Zixuan Zheng; Peng Hu; Zhenyu Li; Dan Huang; Yihan Liu; Chenyang Jiang; Man Li; Siqi Li; Tong Meng; Daoke Yang; Zongqiang Huang
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 4.  DNA repair in cancer initiation, progression, and therapy-a double-edged sword.

Authors:  Katarzyna Kiwerska; Krzysztof Szyfter
Journal:  J Appl Genet       Date:  2019-08-30       Impact factor: 3.240

Review 5.  Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.

Authors:  Shian-Ren Lin; Chia-Hsiang Chang; Che-Fang Hsu; May-Jwan Tsai; Henrich Cheng; Max K Leong; Ping-Jyun Sung; Jian-Chyi Chen; Ching-Feng Weng
Journal:  Br J Pharmacol       Date:  2019-11-27       Impact factor: 8.739

6.  Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma.

Authors:  Liang Wang; Steven Mo; Xin Li; Yingzhi He; Jing Yang
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

7.  Chloroquine reverses chemoresistance via upregulation of p21WAF1/CIP1 and autophagy inhibition in ovarian cancer.

Authors:  Jae Ryoung Hwang; Woo Young Kim; Young-Jae Cho; Ji-Yoon Ryu; Jung-Joo Choi; Soo Young Jeong; Myeong-Sun Kim; Ji Hye Kim; E Sun Paik; Yoo-Young Lee; Hee-Dong Han; Jeong-Won Lee
Journal:  Cell Death Dis       Date:  2020-12-04       Impact factor: 8.469

8.  DNA damage and antioxidant properties of CORM-2 in normal and cancer cells.

Authors:  Michał Juszczak; Magdalena Kluska; Daniel Wysokiński; Katarzyna Woźniak
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

9.  The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.

Authors:  Xinyuan Ding; Yuting Gu; Min Jin; Xin Guo; Sudong Xue; Caihong Tan; Jiefang Huang; Wanlin Yang; Mingxing Xue; Qianjun Zhou; Wenjuan Wang; Yanyun Zhang
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

10.  Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis.

Authors:  Ningning Zhang; Yushu Ouyang; Jianlan Chang; Ping Liu; Xiangyang Tian; Junyan Yu
Journal:  Biomed Res Int       Date:  2020-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.